Project profile — Combatting Antimicrobial Resistance


WHO - World Health Organization (41143)
2017-03-10 - 2018-08-31
Global Affairs Canada
MFM Global Issues & Dev.Branch

Country / region 

• Africa, regional (33.30%)
• America, regional (33.30%)
• Asia, regional (33.40%)


• Health, General: Health policy and administrative management (12110) (50.00%)
• Basic Health: Infectious disease control (12250) (50.00%)

Policy marker 

• Gender equality (not targeted)
• Environmental sustainability (cross-cutting) (not targeted)
• Participatory development and good governance (not targeted)
• Trade development (not targeted)
• Biodiversity (not targeted)
• Climate change mitigation (not targeted)
• Climate Change Adaptation (not targeted)
• Urban issues (not targeted)
• Desertification (not targeted)
• Children's issues (not targeted)
• Youth Issues (not targeted)
• Indigenous Issues (not targeted)
• Disability (not targeted)
• ICT as a tool for development (not targeted)


This project aims to decrease the impact of antimicrobial resistance (AMR), particularly in low- and middle-income countries. Interventions take place across the first four objectives of the Global Action Plan on AMR, which focus on increasing awareness of AMR as a public health threat; improving capacity to monitor AMR patterns, consumption and use; strengthening capacity in infection prevention and control; and strengthening systems to optimize use of antibiotics. The project also includes a component that reinforces linkages to combat AMR across the World Health Organization, with Member States and partners. The Public Health Agency of Canada is a technical partner in this project.

Expected results 

The expected intermediate outcomes of this project include: (1) enhanced coordination and evidence-based policy-making and planning among national and international actors; and (2) enhanced responsible and effective use of antibiotics at hospital and community level in selected low- and middle-income countries.

Results achieved 

Results achieved by WHO through the support of the Government of Canada and other international donors in 2017-2018 include: (1) strengthened health systems in low- and middle-income countries through the development of national action plans (NAPs) on antimicrobial resistance (AMR) and improvements in the prevention and treatment of infectious diseases; (2) improved data collection on and knowledge around the use of antimicrobial drugs to inform policy and practice and implement NAPs; and (3) strengthened global AMR surveillance systems to guide appropriate action on the consumption, use, quality and safety of medicines to ensure the ability to treat and prevent infectious diseases.

Budget and spending 

Original budget $0
Planned disbursement $0
Country percentages by sector
Type of finance Aid grant excluding debt reorganisation
Collaboration type Bilateral
Type of aid Project-type interventions
Date modified: